PPF
REGN icon

PFA Pension Forsikringsaktieselskab’s Regeneron Pharmaceuticals REGN Stock Holding History

PFA Pension Forsikringsaktieselskab’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.6M Sell
90,710
-2,146
-2% -$1.46M 0.14% 163
2026
Q1 		$71.7M Buy
92,856
+6
+0% +$4.59K 0.22% 120
2025
Q4 		$71.9M Buy
+92,850
New +$63.1M 0.2% 124

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PFA Pension Forsikringsaktieselskab's REGN Position: Q2 2026 in Review

PFA Pension Forsikringsaktieselskab reduced its Regeneron Pharmaceuticals (REGN) stake by 2.3% in Q2 2026, selling an estimated $1.46M and leaving 90,710 shares worth $56.6M. The position accounts for 0.14% of the portfolio, ranked #163.

PFA Pension Forsikringsaktieselskab first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $71.9M in Q4 2025. 961 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • PFA Pension Forsikringsaktieselskab held 90,710 shares of Regeneron Pharmaceuticals worth $56.6M as of Q2 2026.
  • PFA Pension Forsikringsaktieselskab sold 2,146 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.46M.
  • Regeneron Pharmaceuticals made up 0.14% of PFA Pension Forsikringsaktieselskab's portfolio in Q2 2026, its #163 holding.
  • PFA Pension Forsikringsaktieselskab first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • PFA Pension Forsikringsaktieselskab's Regeneron Pharmaceuticals position peaked at $71.9M in Q4 2025.
  • 961 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on PFA Pension Forsikringsaktieselskab's 13F filing for Q2 2026, filed 12 Aug 2026.